£15.00 ex. VAT — or £15.00 ex. VAT every 3 months
If you have been diagnosed with Parkinson’s then you may be eligible for a VAT exemption. When checking out, please ensure you fill in the ‘Do you have Parkinson’s?’ section.
The CUE1 Adhesive Patch Pack contains:
These adhesive patches are intended solely for use with the CUE1. Each patch lasts for up to 14 days, depending upon the level of usage.
Please note that these patches have only been made available for the purposes of Charco’s beta testing of the CUE1, and are not intended for general sale. This item only ships to the United Kingdom. We apologise for any inconvenience this may cause.
Instructions for Use
Parkinson’s is a neurodegenerative disorder affecting 10 million people worldwide. Despite the best available medical and surgical interventions, people with Parkinson’s are often frustrated, as they remain significantly limited in their activities. Charco Neurotech, established in 2019 by Lucy Jung and Floyd Pierres, was founded with one ambition: to bring back smiles for people with Parkinson’s. This led to our design of the CUE1, a non-invasive wearable device. The CUE1 aims to alleviate certain Parkinson’s symptoms, including stiffness and slowness of movement. It achieves this by utilising two vibration-based therapies, focussed stimulation and cueing, both of which are research-validated. It also incorporates discreet medication reminders and an accompanying app, enabling the user to track their symptoms.
Parkinson’s affects everyone differently, and the support which Charco offers reflects this. Developments such as the CUE1 allow the person with Parkinson’s to be at the centre of their treatment, and tailor the management of their symptoms to their own unique lives. During our pilot testing of the CUE1, we have consistently recorded average improvements during use of the device, with participants reporting smoother and quicker movements. Through these innovations, we hope to improve quality of life for all 💙.
To find out more, please visit our Frequently Asked Questions page, or reach out to us on [email protected].